跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-203
首页
药物
AT-203
AT-203
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Stable phi29 DNA polymerase having high enzyme activity, and encoding gene and application thereof
US 12655399 B2
申请人: BGI SHENZHEN
优先权: 2020
CN
EP
US
WO
5 件公开
METHODS AND SYSTEMS FOR ADAPTING PATHLENGTH AND/OR WAVELENGTH OF A UV-ABSORBANCE CELL IN A CHROMATOGRAPHY SYSTEM
EP 3586123 A2
申请人: GE HEALTHCARE BIO SCIENCES AB
优先权: 2017
CN
EP
US
WO
4 件公开
MODIFIED PLANTS COMPRISING A POLYNUCLEOTIDE COMPRISING A NON-COGNATE PROMOTER OPERABLY LINKED TO A CODING SEQUENCE THAT ENCODES A TRANSCRIPTION FACTOR
EP 3969466 A4
申请人: YIELD10 BIOSCIENCE INC
优先权: 2019
EP
US
WO
4 件公开
Genetic variant of the annexin A5 gene
US 8119341 B2
申请人: BOGDANOVA NADJA
优先权: 2004
US
4 件公开
Fluorescent GFP variant displaying highly increased fluorescence intensity without a spectral shift
US 8742081 B2
申请人: BUERSTEDDE JEAN-MARIE
优先权: 2007
EP
US
3 件公开
Thrombin Derivatives And Medicinal Composition Containing The Same
US 2007282095 A1
申请人: HOSOKAWA KAZUYA
优先权: 2004
CN
US
2 件公开
Antibodies with reduced binding to process impurities
US 11254753 B2
申请人: GLAXOSMITHKLINE IP DEV LTD
优先权: 2016
CN
US
2 件公开
LAG-3 PROTEIN MUTANT, AND PREPARATION AND USE THEREOF
US 2024247043 A1
申请人: WUHAN YZY BIOPHARMA CO LTD
优先权: 2021
CN
US
2 件公开
SIRNA FOR INHIBITING CIDEB GENE EXPRESSION, DRUG AND APPLICATION THEREOF
WO 2024109722 A1
申请人: BEBETTER MED INC
优先权: 2022
CN
WO
2 件公开
Multiply-substituted protease variants
US 2003073222 A1
申请人: POULOSE AYROOKARAN J
优先权: 2001
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈